Healthcare platform CureBay has raised $21 million in its Series B funding round. In another development, BlackRock is in advanced discussions to invest Rs500 crore in the promoter group of B9 Beverages, maker of Bira91 craft beers.
CureBay raises $21m led by BII
Healthcare platform CureBay has raised $21 million in its Series B funding round led by Bertelsmann India Investments (BII), it announced on Tuesday.
The round saw participation from existing investor Elevar Equity, it said in a statement.
The latest capital infusion will be deployed to strengthen CureBay’s in-house, proprietary
technology stack, expand operations across India, and to build teams. The company aims to expand its footprint to new states, including Jharkhand, Bihar, Uttar Pradesh and Madhya Pradesh. Besides, it will also invest in platform upgrades, proprietary algorithms and rural-first workflow automation tools.
Launched in 2021 and headquartered in Odisha, CureBay provides quality, accessible and affordable services for doctor consultation, diagnostics, pharmacy and tertiary care for rural households through its network of 150+ eClinics operational across Odisha and Chhattisgarh. Its preventive health program boasts 90,000 active members with a renewal rate exceeding 60%.
“With an active network of 150+ eClinics and 1,000+ Swasthya Mitras, we are solving for Bharat, where a large part of the population still lacks access to dependable care. The capital will help us scale technology, talent, and reach to bring dignified, affordable healthcare to the last mile,” said Priyadarshi Mohapatra, Founder and CEO of CureBay.
BlackRock eyes Bira91
American asset management firm BlackRock is in advanced discussions to invest Rs500 crore in the promoter group of B9 Beverages, maker of Bira91 craft beers, through a structured debt deal, The Economic Times reported citing multiple sources.
The funds, set to be injected into holding companies controlled by B9 Beverages promoter Ankur Jain, will be used to buy out early investors, including Peak XV Partners and Sofina, and to infuse fresh capital into B9 Beverages, the report said.
Bira91 reportedly scooped up $50 million across three funding rounds last year from multiple investors including Tiger Pacific Capital and Kirin Holdings. In 2024, B9 Beverages reported a revenue of Rs638 crore and a net loss of Rs748 crore. The loss surpassed the revenue, with a 68% increase from the previous year.
Bira 91 offers a diverse lineup of beer variants, including Bira White, Gold, Bira Blonde, and Boom Super Strong, among others. The company operates across over 1,000 towns in 25 countries and produces its beer at six breweries located in India.
